Sabra Health Care downgraded to Hold from Buy at Truist
Truist downgraded Sabra Health Care (SBRA) to Hold from Buy with a price target of $17, down from $18.Stay Ahead of the Market:Discover ...
Sabra Health Care downgraded to Hold from Buy at Truist on relative valuation
Truist analyst Michael Lewis downgraded Sabra Health Care (SBRA) to Hold from Buy with a price target of $17, down from $18. The firm cites ...